Ublituximab Treatment Is Associated With a Significant Proportion of Participants Achieving NEDA-4

Drug Category : Array
Conference Category : Array
Lead Author : Alvarez E, et al.
Published Date : 26/10/2022
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2022/10/1055-TGTX-ECTRIMS-2022-NEDA-4-26Sept22b.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top